Clinical Trial Update: Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing imipenem/relebactam/cilastatin to piperacillin/tazobactam for bacterial pneumonia completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Pneumonia

Drugs mentioned

• Piperacillin/tazobactam (Piperacillin/tazobactam)
• imipenem/relebactam/cilastatin (imipenem/relebactam/cilastatin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Bacterial Pneumonia | Phase 3 | Status: COMPLETED | Results posted: 2020-04-16